54
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Boussignac CPAP system for brain death confirmation with apneic test in case of acute lung injury/adult respiratory distress syndrome – series of cases

&
Pages 961-965 | Published online: 17 Jun 2015

Abstract

Introduction

There are some patients with severe respiratory disturbances like adult respiratory distress syndrome (ARDS) and suspicion of brain death, for whom typical performance of the apneic test is difficult to complete because of quick desaturation and rapid deterioration without effective ventilation. To avoid failure of brain death confirmation and possible loss of organ donation another approach to apneic test is needed. We present two cases of patients with clinical symptoms of brain death, with lung pathology (acute lung injury, ARDS, lung embolism and lung infection), in whom apneic tests for recognizing brain death were difficult to perform. During typical performance of apneic test involving the use of oxygen catheter for apneic oxygenation we observed severe desaturation with growing hypotension and hemodynamic destabilization. But with the use of Boussignac CPAP system all necessary tests were successfully completed, confirming the patient’s brain death, which gave us the opportunity to perform procedures for organ donation. The main reason of apneic test difficulties was severe gas exchange disturbances secondary to ARDS. Thus lack of positive end expiratory pressure during classical performance of apneic test leads to quick desaturation and rapid hemodynamic deterioration, limiting the observation period below dedicated at least 10-minute interval.

Conclusion

The Boussignac CPAP system may be an effective tool for performing transparent apneic test in case of serious respiratory disturbances, especially in the form of acute lung injury or ARDS.

Introduction

In many countries there is a growing problem of organ shortage for transplantation. Many initiatives have been introduced all over the world to improve both the qualification process and the accessibility of potential organ donors.Citation1Citation3 Although there is large variability between different countries and centers regarding brain death determination criteriaCitation4,Citation5 the apneic test for confirmation of the irreversible lack of spontaneous respiratory pattern is one of the most commonly accepted and performed tests. Typical performance of this test involves the use of an oxygen catheter for apneic oxygenation of the patient’s lungs to avoid possible hypoxia during the procedure. This technique of apneic oxygenation has some limitationsCitation6,Citation7 but in most cases is an effective tool for sufficient oxygenation of the patient. However, there are some patients with severe respiratory disturbances and suspicion of brain death, for whom typical performance of the apneic test is difficult to complete because of quick desaturation and rapid deterioration without effective ventilation. To avoid failure of brain death confirmation and possible organ donation loss there is a necessity for the use of another approach to the apneic test.Citation8 The alternative protocols for apneic test were previously successfully checked, with the use of CPAP system for patients with oxygenation difficulties.Citation9 Additionally the application of CPAP with the use of anesthesia machine circuit systemCitation10 or CPAP valve with recruitment maneuverCitation11 were prescribed for the stabilization of oxygenation during apneic test. We implemented an alternative method with the use of Boussignac virtual valve (Boussignac CPAP system, Vygon, Ecouen, France) for positive end expiratory pressure (PEEP) creation during apneic test. The Boussignac CPAP system was previously successfully applied in clinical use in cases of spontaneously breathing patients with respiratory difficulties.Citation12Citation14 The main advantages of this method are simple construction of the small device and lack of possibility for artificially created ventilation, which is important for transparency of apneic test and effectiveness in functional residual capacity (FRC) stabilization.

Case 1 report

The 36-year old patient was admitted to the intensive care unit (ICU) because of respiratory insufficiency during severe intracranial hemorrhage. He initially presented signs of acute lung injury, probably because of previous gastric content aspiration during initial period of neurological deterioration, evolving into full scale adult respiratory distress syndrome (ARDS) (). After patient stabilization with the use of ventilation therapy and catecholamine infusions we observed progressive deterioration of central nervous system functions, including deep unconsciousness and loss of all brainstem functions, indicating possible brain death. To confirm the suspicion of brain death we completed the law regulated diagnostic protocol for brain death diagnosis, including two apneic tests performed with appropriate time interval. It involved prerequisite fulfillment: after the period of observation confirmation of deep comatose state with diagnosed origin, presence of full scale artificial ventilation without spontaneous efforts, confirmation of irreversible brain damage and exclusion of toxicological disorders, hypothermia 35°C and below, and severe metabolic and endocrine disorders. The next part of the procedure involves two sets of tests performed with appropriate to the clinical situation time interval. The tests consist of positive confirmation of lack of brain stem reflexes and functions: corneal reflex, both spontaneous eye movement and eye movement during caloric test, brain–eye reflex, iris reaction to light, coughing and vomiting reflexes, respiratory pattern, and lack of reaction to pain stimuli. According to the Polish guidelines, before the apneic test initiation the patient was pre-oxygenated during mechanical ventilation with the use of FiO2 =1,0 through 10 minutes. The mechanical parameters of mechanical ventilation were established to achieve PaCO2 value of at least 40 mmHg, avoiding hyperventilation. During typical performance of this test involving the use of oxygen catheter for apneic oxygenation we observed severe desaturation with growing hypotension and hemodynamic destabilization, creating risk of immediate cardiac arrest (first test). There were no observed respiratory efforts, or any other spontaneous activity of the patient, but quick desaturation and rapid deterioration with both speeds of oxygen delivery 6 L/min and 15 L/min which had created the need for return to mechanical ventilation, without enough long observation period for proper assessment. To eliminate all possible concerns about achieved results we performed additional apneic tests with the use of Boussignac CPAP system (). The use of Boussignac CPAP system with oxygen flow 15 L/min created enough stabilization for apneic test performance without circulatory deterioration. During apneic tests performed with the use of Boussignac virtual valve we observed much smaller disturbances, with stable hemodynamic function and much more acceptable saturation (second test). Between the series of tests pan-angiography was performed, which confirmed total lack of cerebral blood flow. All necessary tests were successfully completed, confirming the patient’s death, which gave us the opportunity to perform procedure for organ donation.Citation15 The main reason for apneic test difficulties was severe gas exchange disturbances secondary to ARDS. During previous period of ventilation the patient needed advanced ventilation protocol with high PEEP value (at least 15 cm H2O) to avoid quick atelectasis formation. Thus, lack of PEEP during classical performance of apneic test led to quick desaturation and rapid hemodynamic deterioration, limiting the observation period to less than the minimum 10-minute interval. Apneic tests with the Boussignac CPAP system showed lack of any observed or monitored spontaneous respiratory effort or activity. Laboratory gas analysis results were: first test (typical apneic test with oxygen insufflation only): pH 7.361/7.157; PaCO2 52.9/93.8 mmHg; PaO2 72.3/52.5 mmHg; SaO2 94.7/78.6%; second test (with Boussignac system): pH 7.338/7.11; PaCO2 56.8/108 mmHg; PaO2 118/78.1 mmHg; SaO2 98.2/91.1%. These data completed the diagnostic protocol confirming the patient’s brain death status.

Figure 1 X-ray of chest of first case – ARDS following massive gastric content aspiration.

Abbreviation: ARDS, adult respiratory distress syndrome.
Figure 1 X-ray of chest of first case – ARDS following massive gastric content aspiration.

Figure 2 Presentation of Boussignac CPAP (Vygon, Ecouen, France) system during apneic test.

Figure 2 Presentation of Boussignac CPAP (Vygon, Ecouen, France) system during apneic test.

Case 2 report

A 39-year old woman was admitted to internal ward because of severe respiratory distress. She complained of breathing difficulty for 2 days, which deteriorated and while presenting to the emergency department she was getting tired quickly and required oxygen supply to maintain SpO2 >90%. Chest X-rays revealed lung embolism complicated by lung infection (). After thrombosis therapy and antibiotics her state improved slightly. On the third day of hospital stay she had sudden respiratory failure and cardiac arrest. After successful resuscitation computed tomography scans of head revealed intracranial bleeding. After admission to ICU she presented signs of brain death. After 24 hours’ observation, tests for determining brain death were started. The patient’s lungs were ventilated with 100% oxygen to achieve 40 mmHg in EtCO2 (). First apneic test was performed with typical method – passive oxygen insufflation via catheter in endotracheal tube. This test was very difficult to perform because of fast desaturation. We decided to perform second apneic test with the use of Boussignac CPAP system (). This test was effective and did not result in desaturation nor hemodynamic instability.

Figure 3 X-ray of chest of second patient – ARDS after lung embolism complicated by lung infection.

Abbreviation: ARDS, adult respiratory distress syndrome.
Figure 3 X-ray of chest of second patient – ARDS after lung embolism complicated by lung infection.

Figure 4 Picture of monitors – at the start of apneic test achieved EtCO2 was 40 mmHg, but in blood gasometry PaCO2 was 74 mmHg.

Note: Drager Infinity C 700 (upper monitor, showing among other parameters EtCO2 – yellow curve and numeric value) and Drager Infinity C 500 for Evita E ventilator (lower panel showing ventilation curves before start point for patient disconnection from ventilator and apneic test).
Figure 4 Picture of monitors – at the start of apneic test achieved EtCO2 was 40 mmHg, but in blood gasometry PaCO2 was 74 mmHg.

Figure 5 Patient during second series of apneic test using Boussignac CPAP system (Vygon, Ecouen, France).

Figure 5 Patient during second series of apneic test using Boussignac CPAP system (Vygon, Ecouen, France).

The laboratory gas analysis results were: first test (typical apneic test with oxygen insufflation only): pH 7.257/6.99; PaCO2 58.2/117 mmHg; PaO2 90.7/83.5 mmHg; SaO2 92.9/87.9%; second test (with Boussignac system): pH 7.11/6.98; PaCO2 74/101 mmHg; PaO2 97/92 mmHg; SaO2 99.6/96.2%.

Discussion

The number of reports involving use of different techniques of PEEP generation during apneic test for FRC and oxygenation stabilization is very limited. Thus there is no standard procedure available for such a clinical situation. On the other hand the apneic test is one of the crucial elements necessary for brain death confirmation and one of the most commonly accepted and performed. Poland as well as a few other countries introduced this test into the law regulated diagnostic protocol for brain death confirmation. In case of unstable patients with severe respiratory disturbances very rarely is there a possibility for successful procedure with the use of oxygen catheter alone, because of deep desaturation and hemodynamic destabilization occurrence. Many different techniques were proposed for such a situation to stabilize FRC and gas exchange.Citation9Citation11 The advantages of Boussignac CPAP device in such a situation are low costs, simple construction of the device, possibility for use together with classical oxygen catheter, and lack of possibility for artificially created ventilation, which is important for transparency of apneic test. Although the last measurements of oxygenation from the second test were below optimal objective, the tests were successfully completed without hemodynamic decompensation. However, this single observation is only a small indication of possible benefits from improved technique of apneic test. Further studies, involving a bigger population of patients, should be performed to establish real value of this improvement of apneic test technique.

Conclusion

The Boussignac CPAP system may be an effective tool for transparent performance of apneic tests in case of serious respiratory disturbances, especially in the form of acute lung injury or ARDS. A randomized multicenter study may be necessary to compare different proposed techniques for such a clinical situation.

Disclosure

The authors have no conflicts of interest to disclose.

References

  • GuptaNGaronzik-WangJMPassarellaRJAssessment of resident and fellow knowledge of the organ donor referral processClin Transplant201428444344924673146
  • NeyrinckAVan RaemdonckDMonbaliuDDonation after circulatory death: current statusCurr Opin Anaesthesiol201326338239023632566
  • ShemieSDHornbyLBakerAInternational guideline development for the determination of deathIntensive Care Med201440678879724664151
  • WijdicksEFBrain deathHandb Clin Neurol201311819120324182378
  • ShappellCNFrankJIHusariKSanchezMGoldenbergFArdeltAPractice variability in brain death determination: a call to actionNeurology201381232009201424198290
  • OlgunerCKocaUAkanMKarciAElarZThe safe limits of mechanical factors in the apnea testing for the diagnosis of brain deathTohoku J Exp Med2007211211512017287594
  • HenryNRMarshallSGApnea testing: the effects of insufflation catheter size and flow on pressure and volume in a test lungRespir Care201459340641023962503
  • Del RíoFEscuderoDDe La CalleBVidalFGParedesMVNúñezJREvaluación y mantenimiento del donante pulmonar [Evaluation and maintenance of the lung donor]Med Intensiva20093314049 Spanish19232208
  • LévesqueSLessardMRNicolePCEfficacy of a T-piece system and a continuous positive airway pressure system for apnea testing in the diagnosis of brain deathCrit Care Med20063482213221616540953
  • ShresthaGSShresthaPSAcharyaSPApnea testing with continuous positive airway pressure for the diagnosis of brain death in a patient with poor baseline oxygenation statusIndian J Crit Care Med201418533133324914266
  • HockerSWhalenFWijdicksEFApnea testing for brain death in severe acute respiratory distress syndrome: a possible solutionNeurocrit Care201420229830024233817
  • DieperinkWJaarsmaTvan der HorstICBoussignac continuous positive airway pressure for the management of acute cardiogenic pulmonary edema: prospective study with a retrospective control groupBMC Cardiovasc Disord200774018096038
  • WongDTAdlyEIpHYThaparSMaxtedGRChungFFA comparison between the Boussignac™ continuous positive airway pressure mask and the venturi mask in terms of improvement in the PaO2/F(I)O2 ratio in morbidly obese patients undergoing bariatric surgery: a randomized controlled trialCan J Anaesth201158653253921465320
  • MoritzFBrousseBGelléeBContinuous positive airway pressure versus bilevel noninvasive ventilation in acute cardiogenic pulmonary edema: a randomized multicenter trialAnn Emerg Med200750666667517764785
  • TrzcinskaMWoderskaAWlodarczykZPsychological principles in regard to interview with the deceased donor’s familyAnaesthesiol Intensive Ther20144720020725078774